A delayed launch. A costly reformulation. A product that clears regulatory review in one market only to face unexpected hurdles in another.
For companies developing and commercializing Health & Nutrition products, navigating international supplement regulations is a common risk when expanding internationally. While products may appear similar across markets, the regulatory frameworks governing Europe, the US and Canada differ in ways that directly influence ingredient selection, formulation, claims, labeling and ultimately, speed to market.
An ingredient that is readily accepted in one region may require a lengthy authorization process, or a completely different regulatory strategy in another. Understanding these differences early helps product teams make more informed decisions around formulation, labeling and market entry, reducing the risk of costly changes later in development
Below are four key regulatory lessons from FoodChain ID’s recent webinar, Navigating Supplement Regulations in Europe, the US and Canada, that every product team should consider when planning an international launch.
1. The same ingredient can have a different regulatory status depending on the market
One of the biggest misconceptions in global product development is assuming that an ingredient approved in one market will automatically be acceptable elsewhere.
- In the European Union, food supplements are regulated as foods under EU food legislation.
- In the United States, dietary supplements fall under the Dietary Supplement Health and Education Act (DSHEA).
- In Canada, Natural Health Products (NHPs) are regulated through a dedicated framework with pre-market licensing requirements under the Natural Health Products Regulations.
These are more than just different names for similar products. Each regulatory framework determines how ingredients are classified, what evidence is required, which authorities oversee compliance and what pathways are available to bring products to market.
For product developers, this means that expanding internationally often requires evaluating ingredient suitability on a market-by-market basis rather than assuming a single global strategy will apply.
2. Innovative ingredients follow different approval pathways around the world
- In the EU, new ingredients may require a Novel Food authorization, which can take more than two years.
- In the US, companies may need to assess whether an ingredient requires an NDI notification or follows another pathway, such as GRAS.
- In Canada, a Product License Application may be required, with review timelines that can extend up to 210 days.
These varying timelines and evidence requirements can significantly influence development priorities, launch sequencing and investment decisions.
Rather than selecting target markets after product development is complete, regulatory considerations should help shape commercial planning from the outset.
3. Ingredient authorization is only part of the regulatory picture
Successfully bringing a Health & Nutrition product to market involves much more than confirming that an ingredient is permitted. Claims and labeling requirements also vary considerably across Europe, the US and Canada.
For example, an antioxidant claim may be treated differently across regions: as a nutrient content claim in the US, a health claim in Europe or part of a pre-market review in Canada.
Likewise, allergen labeling is required in all three regions, but the regulated allergens, wording and presentation format are not identical.
As a result, claims strategy and labeling should be evaluated individually for each target market rather than adapted at the final stage of commercialization.
Taking this approach early can help avoid unnecessary redesigns, delayed launches and additional regulatory reviews.
4. Scientific substantiation remains the foundation of successful market access
Although regulatory requirements differ across regions, one principle remains consistent: robust scientific evidence is essential. Whether supporting ingredient safety, market authorization or product claims, companies need a strong evidence base that aligns with local regulatory expectations.
Depending on the regulatory pathway, this may include clinical studies, toxicological assessments, scientific literature, meta-analyses and regulatory precedent from authorities such as the FDA, EFSA or Health Canada.
While each jurisdiction evaluates evidence differently, companies that develop a comprehensive scientific foundation can often leverage much of the same data across multiple markets, adapting submissions to meet local requirements rather than rebuilding evidence from scratch.
Viewed this way, scientific substantiation becomes more than a regulatory requirement, it becomes a strategic asset that supports faster expansion and more confident decision-making.
Bringing Health & Nutrition products to international markets is no longer just a regulatory exercise; it’s a strategic one. It requires more than understanding a single set of regulations. Ingredient status, authorization pathways, claims and labeling requirements all vary across Europe, the US and Canada, making market-specific regulatory planning an essential part of product development.
While navigating these differences can be complex, understanding them early enables organizations to make better development decisions, reduce regulatory risk and prepare more effectively for international expansion.
Companies that achieve the greatest success globally aren’t necessarily those that move the fastest, they’re the ones that plan with regulatory requirements in mind from the very beginning.
Learn more
To learn more about navigating regulatory requirements for Health & Nutrition products, watch FoodChain ID’s webinar Navigating Supplement Regulations in Europe, the US and Canada.
If you’re planning international market expansion, FoodChain ID combines regulatory intelligence, scientific expertise and consulting services to help companies navigate complex global requirements with greater confidence.